Because of analysis led by the director of the National Institutes of Health, Francis Collins, MD, PhD, a treatment that may provide longer, better lives to children with HutchinsonGilford progeria syndrome now’s in clinical trials. Children born with this type of progeria become strikingly wizened as they age without ever growing to adulthood. They die by about age 12 or so, normally as a consequence of heart disease. Progeria has often been portrayed as a cartoon of aging, from which little may very well be realized about normal aging, in response to Collins, this years Charles J. and Lois B. Epstein Visiting Professor. He doesn’t share this view. I suppose we will counter that with molecular data, he mentioned throughout a talk on the UCSF Mission Bay campus on Oct. 3, a part of a daylong symposium hosted by the Institute for Human Genetics. The frequent wrongdoer Collins has identified in regular and premature aging arises for various reasons. In regular aging, Collins suspects harm or loss of telomeres protecting DNA that caps genes at the ideas of chromosomes within all our residing cells. Telomeres appear to be turning up everywhere in aging research.